2012 || Oncology || Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012 || Aarkstore.com

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2
2012
http://www.aarkstore.com/reports/Muscle-Invasive-Bladder-Cancer-MIBC-
Pipeline-Review-H2-2012-220602.html
RSS link of Global Markets Direct
http://www.aarkstore.com/feeds/Global-Markets-Direct.xml
Summary
Global Markets Direct’s, Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review,
H2 2012, provides an overview of the Muscle Invasive Bladder Cancer (MIBC)
therapeutic pipeline. This report provides information on the therapeutic
development for Muscle Invasive Bladder Cancer (MIBC), complete with latest
updates, and special features on late-stage and discontinued projects. It also reviews
key players involved in the therapeutic development for Muscle Invasive Bladder
Cancer (MIBC). Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2012
is built using data and information sourced from Global Markets Direct’s proprietary
databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Muscle Invasive Bladder Cancer
(MIBC).
- A review of the Muscle Invasive Bladder Cancer (MIBC) products under

2. development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
- Coverage of the
Table of contents:
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Muscle Invasive Bladder Cancer (MIBC) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Muscle Invasive Bladder Cancer (MIBC) 7
Muscle Invasive Bladder Cancer (MIBC) Therapeutics under Development by
Companies 9
Muscle Invasive Bladder Cancer (MIBC) Therapeutics under Investigation by
Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Muscle Invasive Bladder Cancer (MIBC) Therapeutics – Products under
Development by Companies 15
Muscle Invasive Bladder Cancer (MIBC) Therapeutics – Products under
Investigation by Universities/Institutes 16
Companies Involved in Muscle Invasive Bladder Cancer (MIBC) Therapeutics
Development 17
Altor BioScience Corporation 17
Muscle Invasive Bladder Cancer (MIBC) – Therapeutics Assessment 18

3. Assessment by Monotherapy Products 18
Assessment by Combination Products 19
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 24
Gemcitabine + Cisplatin + Sunitinib - Drug Profile 24
Product Description 24
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Cholangiocellular Hepatoma – Pipeline Review, H2 2012
Hormone Refractory Breast Cancer – Pipeline Review, H2 2012
Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012
Refractory Multiple Myeloma – Pipeline Review, H2 2012
Epithelial Ovarian Cancer – Pipeline Review, H2 2012
Neuro Endocrine (Carcinoid) Carcinoma – Pipeline Review, H2 2012

4. B-Cell Leukemia – Pipeline Review, H2 2012
Malignant Neoplasms – Pipeline Review, H2 2012
Recurrent Malignant Glioma – Pipeline Review, H2 2012
Endobronchial Cancer – Pipeline Review, H2 2012
Leiomyosarcoma – Pipeline Review, H2 2012
Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H2 2012
Esophageal Tumor – Pipeline Review, H2 2012
Malignant Pleural Mesothelioma – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
You can also request for sample page of above mention reports on
sample@aarkstore.com
For More details Plz do contact :
Aarkstore Enterprise
Lavanya

5. Phone:08149852585
Email: enquiry@aarkstore.com